Pioglitazone Reduces β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer’s Disease

類似資料

• Ginsenoside Rg1 reduces β-amyloid levels by inhibiting CDK5-induced PPARγ phosphorylation in a neuron model of Alzheimer's disease
  著者:: Quan, Qiankun, 等
  出版事項: (2020)
• Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation
  著者:: Liu, Li-ping, 等
  出版事項: (2013)
• Ginsenoside Rg1 Decreases Aβ(1–42) Level by Upregulating PPARγ and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease
  著者:: Quan, QianKun, 等
  出版事項: (2013)
• PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
  著者:: Katsouri, Loukia, 等
  出版事項: (2016)
• A rapid, PPAR-γ-dependent effect of pioglitazone on the phosphorylation of MYPT
  著者:: Atkins, Kevin B., 等
  出版事項: (2009)